| 000 | 03089nam a22003975i 4500 | ||
|---|---|---|---|
| 999 |
_c10130 _d10130 |
||
| 001 | 10130 | ||
| 003 | DE-He213 | ||
| 005 | 20210608040354.0 | ||
| 006 | a||||fo|||| 00| 0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 171214s2018 gw | s |||| 0|eng d | ||
| 020 | _a9783658205911 | ||
| 024 | 7 |
_a10.1007/978-3-658-20591-1 _2doi |
|
| 040 |
_aES-MaUEC _bspa _dES-VaUE |
||
| 050 | 4 |
_aRC254.5 _b.K785 2018 EB |
|
| 090 | 4 | _aRD651-678 | |
| 100 | 1 |
_aKrukemeyer, Manfred Georg. _eautor. _4aut _4http://id.loc.gov/vocabulary/relators/aut _0http://id.loc.gov/authorities/names/n2006072601 |
|
| 245 | 1 | 0 |
_aExperimental Investigations into Sarcomas: _bTherapy Using Ferromagnetically Induced Cytostatics _cby Manfred Georg Krukemeyer. |
| 264 | 1 |
_aWiesbaden _bSpringer Fachmedien Wiesbaden : _bImprint: Springer _c2018. |
|
| 300 | _a1 recurso en línea (XII, 122 páginas 39 ilustraciones, 21 ilustraciones a color) | ||
| 336 |
_2rdacontent _aTexto (visual) _btxt |
||
| 337 |
_2rdamedia _aelectrónico _bc |
||
| 338 |
_2rdacarrier _arecurso electrónico _bcr |
||
| 347 |
_atext file _bPDF |
||
| 490 | 0 | _aMedicine (Springer-11650) | |
| 520 | 3 | _aManfred Georg Krukemeyer first describes magnetic drug targeting, by which is meant the focused application of drugs, e.g. the introduction of a cytostatic, and which is aimed at optimising its locally therapeutic effect. The author thus achieves a high concentration of cytostatic at the site of the tumour. The particles have to be large enough to be attracted by a magnetic field and so find their way into the tumour, where they release their active ingredient. The aim of the hypothesis formed by one of the author’s study groups was to show in a scientific experiment that in this case cytostatics coupled with iron particles [Fe3O4] can be introduced into a tumour. The focused introduction of drugs – magnetic drug targeting – results in faster arrival of the active ingredient at the target site together with a reduced quantity of active substances. For this reason magnetic drug targeting is also interesting from an economic point of view. Contents Sarcomas and their Pathology Magnetic Drug Targeting Animal Testing and Patient Examination, Tumour Therapy in Humans Target groups Researchers, teachers and students in surgical and oncology departments Doctors working in the fields of surgery and oncology About the author Dr. med. Manfred Georg Krukemeyer is a specialist surgeon currently holding a senior position at a large German hospital enterprise. | |
| 653 | 0 | _aSurgical oncology. | |
| 653 | 0 | _aOncology . | |
| 653 | 1 | 4 | _aSurgical Oncology. |
| 710 | 2 |
_aSpringerLink (Online service) _0http://id.loc.gov/authorities/names/no2005046756 _0http://viaf.org/viaf/148105729 _9106996 |
|
| 776 | 0 | 8 |
_iEdición impresa: _z9783658205904 |
| 776 | 0 | 8 |
_iEdición impresa: _z9783658205928 |
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-658-20591-1 _zAcceso a este recurso digital (usuarios Universidad Europea de Valencia) |
| 942 |
_2lcc _cLE |
||
| 998 | _db | ||